Although the brain requires abundant cholesterol for myelin sheaths, central nervous system cholesterol is synthesized locally by astrocytes rather than imported from blood. Because hydrophilic statins (rosuvastatin, pravastatin) cannot cross the blood-brain barrier, they lower systemic cardiovascular risk without depleting cerebral cholesterol.